Figure 4. High IGF2BP2 expression is associated with poor survival in OSCC patients.
(A) Overall survival of IGF2BP2high and IGF2BP2low patients analyzed with the dataset, GSE42743. (B) Overall survival of IGF2BP2high and IGF2BP2low OSCC patients analyzed with TCGA (n=311). (C) Overall survival of IGF2BP2high and IGF2BP2low OSCC patients analyzed with clinical samples (n=30).
